The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Foresite Capital Opportunity Management V, Llc since 2021.
This trader's CIK number is 1792207.
At the time of last reporting, Foresite Capital Opportunity Management V, Llc was the 10% Owner of Kinnate Biopharma Inc.. (stock ticker symbol KNTE).
Also see all insider trading activities at Kinnate Biopharma Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | PRDS | 325,000 | $3,250,000 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | KNTE | 1,780,000 | $4,984,000 | 0 | $0 | 0 | $0 |
1. Pardes Biosciences, Inc. (PRDS)
2. Kinnate Biopharma Inc. (KNTE)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-12-22 | PRDS | Buy | 325,000 | 10.00 | 3,250,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-05-08 | KNTE | Buy | 1,780,000 | 2.80 | 4,984,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Foresite Capital Opportunity Management V, Llc (10% Owner of Kinnate Biopharma Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.